Novartis 3Q Revenues: $9.6 billion (+9%) 3Q Earnings: $6.8 billion (+267%) YTD Revenues: $28.1 billion (+13%) YTD Earnings: $11.0 billion (+100%) Comments: Net earnings included $5.2 billion from the sale of the Medical Nutrition and Gerber units. Without that boost, net earnings for 3Q would have been $1.6 billion (-12%) and $5.6 billion YTD (+7%). Pharma sales were up 2% in 3Q to $5.9 billion, and up 8% to $17.9 billion YTD. With the earnings announcement, Novartis announced lay...